Plant-based medicine for hepatitis C is goal of state-assisted study by Cornell scientist and Ithaca company

The human hepatitis C virus is a target of drug-discovery research by a Cornell scientist and an Ithaca company, among the latest recipients of support from the New York Science, Technology and Academic Research program.

Growers gain a Cornell-tested, environmentally friendlier strategy in their Integrated Pest Management program

The U.S. Environmental Protection Agency has granted a one-year approval for a novel plant protectant that has been tested at Cornell University as a seed coating for onions. This new treatment promises to help save New York's onion crop, providing that it can gain full approval for use beyond 1996.